Adhesive transdermal medicament patch

Yanaki September 2, 2

Patent Grant D576282

U.S. patent number D576,282 [Application Number D/261,600] was granted by the patent office on 2008-09-02 for adhesive transdermal medicament patch. This patent grant is currently assigned to ActivaTek, Inc.. Invention is credited to Jamal S. Yanaki.


United States Patent D576,282
Yanaki September 2, 2008

Adhesive transdermal medicament patch

Claims

CLAIM What is claimed is the ornamental design for an adhesive transdermal medicament patch, as shown and described.
Inventors: Yanaki; Jamal S. (Salt Lake City, UT)
Assignee: ActivaTek, Inc. (Salt Lake City, UT)
Appl. No.: D/261,600
Filed: June 16, 2006

Current U.S. Class: D24/189
Current International Class: 2404
Field of Search: ;D24/188-189 ;602/41-48,52,54-58 ;D6/354

References Cited [Referenced By]

U.S. Patent Documents
3342183 September 1967 Edenbaum
3797494 March 1974 Zaffaroni
4141359 February 1979 Jacobsen et al.
4250878 February 1981 Jacobsen et al.
4416274 November 1983 Jacobsen et al.
4474570 October 1984 Ariura et al.
4557723 December 1985 Sibalis
4619654 October 1986 Abplanalp
4627429 December 1986 Tsuk
D292826 November 1987 Sproles
D295077 April 1988 Wagle et al.
D295078 April 1988 Wagle et al.
D295079 April 1988 Wagle et al.
D296006 May 1988 Asche
4752285 June 1988 Petelenz
4820263 April 1989 Spevak
4927408 May 1990 Haak et al.
5125894 June 1992 Phipps et al.
D343684 January 1994 Paton et al.
D349960 August 1994 Gyory et al.
D352113 November 1994 Ashley
D352357 November 1994 Ashley
D352782 November 1994 Kirk, III et al.
D357742 April 1995 Peery et al.
D357743 April 1995 Bilitz
D359805 June 1995 Mikler et al.
D359806 June 1995 Mikler et al.
D359807 June 1995 Mikler et al.
D362912 October 1995 Albert
D363126 October 1995 Dusek
D366702 January 1996 Kirk, III et al.
D372097 July 1996 Albert et al.
D372098 July 1996 Lattin et al.
D377529 January 1997 Nyqvist-Mayer
D380552 July 1997 Frenkel et al.
D382343 August 1997 Wandell et al.
D384745 October 1997 Lattin et al.
5681580 October 1997 Jang et al.
D389581 January 1998 Fein
5736153 April 1998 Lamers
5833665 November 1998 Bootman et al.
5978701 November 1999 Johnson et al.
5983130 November 1999 Phipps et al.
6035234 March 2000 Riddle et al.
6086572 July 2000 Johnson et al.
6192270 February 2001 Hofmann et al.
6261595 July 2001 Stanley et al.
6377847 April 2002 Keusch et al.
D456623 May 2002 Yates
6421561 July 2002 Morris
6505069 January 2003 Scott et al.
D477086 July 2003 Tsuruda et al.
6653014 November 2003 Anderson et al.
6738662 May 2004 Frank
6745071 June 2004 Anderson et al.
6748265 June 2004 Hofmann et al.
D493230 July 2004 Liedtke et al.
6775569 August 2004 Mori
6775570 August 2004 Joshi
6842640 January 2005 Riddle et al.
D501926 February 2005 Shaw et al.
6862473 March 2005 Keusch et al.
6915159 July 2005 Kuribayashi et al.
D537947 March 2007 Miyachika et al.
D544607 June 2007 Henry et al.
D545440 June 2007 Jensen
2004/0143210 July 2004 Shevlin
2004/0225253 November 2004 Shevlin
2005/0143686 June 2005 Shevlin

Other References

Empi, "Action Patch, the Smart Iontophoresis System.TM." product literature, available at http://www.empi.com/products/ionot.cfm (accessed Oct. 4, 2005). cited by other .
Empi, "Important Features of Dupel B.L.U.E.TM." product literature .COPYRGT. 2002, available at http://www.empi.com/products/ionto/dupel2.pdf (accessed Oct. 4, 2005). cited by other .
Eemso, E-Strip product sample (acquired circa Oct. 2005). cited by other .
Iomed, Inc., "Iomed.RTM. First in Iontophoresis" trade literature .COPYRGT. 2005, available at http://www.iomed.com/pdf/iomed%brochure%20rev0C.pdf (accessed Oct. 4, 2005). cited by other .
Iomed, Inc., "Quality . . . Measured in Outcomes" product literature .COPYRGT. 2005, available at http://www.iomed.com/ (accessed Oct. 4, 2005). cited by other .
Iomed, Inc., Iogel.TM. system sample components (acquired circa Oct. 2005). cited by other .
Iomed, Inc., Companion 80.TM. product sample (acquired circa Oct. 2005). cited by other .
Travanti Pharma, Inc., "IontoPatch.RTM. Device" product literature .COPYRGT. 2002, available at http://www.travantipharma.com/markets.sub.--iontioatch.sub.--device.html (accessed Oct. 4, 2005). cited by other .
Travanti Pharma, Inc., "IontoPatch.TM.--Iontophoresis with the Battery Built-in" product literature, available at http://www.travantipharma.com/pdf/IontoPatch.sub.--info.pdf (accessed Oct. 4, 2005). cited by other .
Travanti Pharma, Inc., IontoPatch.RTM. product sample (acquired circa Oct. 2005). cited by other .
Travanti Pharma, Inc., "WEDD.RTM. Strengths" product literature .COPYRGT. 2002, available at http://www.travantipharma.com/technology.sub.--strengths.html (accessed Oct. 4, 2005). cited by other .
Travanti Pharma, Inc., "WEDD.RTM. Targets" product literature .COPYRGT. 2002, available at http://www.travantipharma.com/markets.sub.--targets.html (accessed Oct. 4, 2005). cited by other .
Travanti Pharma, Inc., "WEDD.RTM. Wearable Electronic Disposable Drug Delivery" product literature .COPYRGT. 2002, available at http://www.travantipharma.com/ (accessed Oct. 4, 2005). cited by other .
Warden, Glenn D., "Electrical Safety in Iontophoresis", 20 Rehab Mgmt 20-23 (Mar. 2007). cited by other.

Primary Examiner: Zarfas; Louis S
Assistant Examiner: Wilson; Michelle E
Attorney, Agent or Firm: Burningham, P.C.; Kent S.

Description



FIG. 1 is a perspective view of a sportsperson wearing on the elbow thereof an adhesive transdermal medicament patch embodying the inventive design;

FIG. 2 is a perspective view of the adhesive transdermal medicament patch of FIG. 1 showing a release sheet for the patch in the process of being peeled from an adhesive coating on the bottom face of the patch;

FIG. 3 is a top plan view of the adhesive transdermal medicament patch of FIGS. 1 and 2;

FIG. 4 is a rear elevation view of the adhesive transdermal medicament patch of FIG. 3;

FIG. 5 is a left elevation side view of the adhesive transdermal medicament patch of FIG. 3;

FIG. 6 is a right elevation side view of the adhesive transdermal medicament patch of FIG. 3;

FIG. 7 is a front elevation view of the adhesive transdermal medicament patch of FIG. 3; and,

FIG. 8 is a bottom plan view of the adhesive transdermal medicament patch of FIG. 3.

The broken line showing of a tennis player, tennis court, and the circular center portion of the patch are included for the purpose of illustrating environmental structure and forms no part of the claimed design.

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed